Type Hypersensitivity
📧 Sign up to get email alerts when something new happens for Type Hypersensitivity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Analysis of the Role of IgE Proteoforms in Health and Disease
KU Leuven is updating on a clinical trial studying the role of IgE proteoforms in health and disease, with recruitment ongoing across severa…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine [Phase 2]
Phase 2 clinical trial evaluating the contribution of Monophosphoryl Lipid A (MPL) to a grass pollen allergy vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test [Phase 2]
Phase 2 trial investigating safety and efficacy of varying doses of RagweedMATAMPL with assessment of residual allergenicity via skin prick …
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen [Phase 2]
Phase 2 trial evaluating different doses of tyrosine adsorbed grass pollen allergoid with MPL in patients with grass pollen hypersensitivity…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen [Phase 2]
Phase 2 trial evaluating different doses of Tyrosine Adsorbed Tree Pollen Allergoid with MPL in patients with Type I Hypersensitivity due to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Efficacy and Safety/Tolerability of Grass MATA MPL [Phase 3]
Phase 3 trial evaluating the efficacy and safety/tolerability of Grass MATA MPL for Type I hypersensitivity has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Efficacy and Safety/Tolerability of Ragweed MATA MPL [Phase 3]
A Phase 3 trial evaluating the efficacy and safety/tolerability of Ragweed MATA MPL for Type I hypersensitivity has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing [Phase 1]
Phase 1 trial assessing residual allergenicity of a tree pollen allergoid (birch, hazel, alder) using skin prick testing; study completed.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing [Phase 1]
This Phase 1 study from Allergy Therapeutics assesses the residual allergenicity of a Grass/Rye Pollen Allergoid using skin prick testing in…